XML 50 R37.htm IDEA: XBRL DOCUMENT v3.23.2
Investments in and Advances to Joint Ventures (Tables)
6 Months Ended
Jun. 30, 2023
Equity Method Investments and Joint Ventures [Abstract]  
Schedule of Financial Information of Consolidated Joint Ventures

The following represents financial information for consolidated joint ventures included in the consolidated financial statements (in thousands):

 

 

 

June 30, 2023

 

 

December 31, 2022

 

Current assets

 

$

374,942

 

 

$

289,837

 

Noncurrent assets

 

 

10,401

 

 

 

9,961

 

Total assets

 

 

385,343

 

 

 

299,798

 

Current liabilities

 

 

242,530

 

 

 

194,701

 

Noncurrent liabilities

 

 

3,399

 

 

 

3,763

 

Total liabilities

 

 

245,929

 

 

 

198,464

 

Total joint venture equity

 

$

139,414

 

 

$

101,334

 

 

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

June 30, 2023

 

 

June 30, 2022

 

 

June 30, 2023

 

 

June 30, 2022

 

Revenue

 

$

167,253

 

 

$

108,089

 

 

$

328,737

 

 

$

203,623

 

Costs

 

 

143,808

 

 

 

98,761

 

 

 

285,406

 

 

 

187,603

 

Net income

 

$

23,445

 

 

$

9,328

 

 

$

43,331

 

 

$

16,020

 

Net income attributable to noncontrolling interests

 

$

11,530

 

 

$

4,485

 

 

$

21,253

 

 

$

7,661

 

Summary of Financial Information for Unconsolidated Joint Ventures

The following represents the financial information of the Company’s unconsolidated joint ventures as presented in their unaudited financial statements (in thousands):

 

 

 

June 30, 2023

 

 

December 31, 2022

 

Current assets

 

$

1,470,305

 

 

$

1,610,246

 

Noncurrent assets

 

 

492,597

 

 

 

491,658

 

Total assets

 

 

1,962,902

 

 

 

2,101,904

 

Current liabilities

 

 

1,032,758

 

 

 

1,255,297

 

Noncurrent liabilities

 

 

518,762

 

 

 

468,056

 

Total liabilities

 

 

1,551,520

 

 

 

1,723,353

 

Total joint venture equity

 

$

411,382

 

 

$

378,551

 

Investments in and advances to unconsolidated joint ventures

 

$

118,861

 

 

$

107,425

 

 

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

June 30, 2023

 

 

June 30, 2022

 

 

June 30, 2023

 

 

June 30, 2022

 

Revenue

 

$

530,467

 

 

$

594,959

 

 

$

879,624

 

 

$

979,540

 

Costs

 

 

534,555

 

 

 

564,239

 

 

 

893,950

 

 

 

937,525

 

Net income

 

$

(4,088

)

 

$

30,720

 

 

$

(14,326

)

 

$

42,015

 

Equity in (losses) earnings of unconsolidated joint ventures

 

$

75

 

 

$

5,613

 

 

$

(5,765

)

 

$

11,211